<DOC>
	<DOCNO>NCT01792817</DOCNO>
	<brief_summary>Multi-center , prospective , double-blind , randomize , sham-controlled pivotal study non-invasive vagus nerve stimulation GammaCoreÂ® device acute treatment cluster headache . The study compare safety effectiveness active treatment ( GammaCore ) sham treatment .</brief_summary>
	<brief_title>Non-invasive Neurostimulation Vagus Nerve Treatment Cluster Headache</brief_title>
	<detailed_description>Phase 1 : Prospective , randomize ( 1:1 active treatment : sham control allocation ) , double blind , sham control treatment ( active sham ) phase Phase 2 : Prospective , non-randomized , active treatment phase . Phase 1 - Two Arms : 1 . Active Treatment GammaCore Device 2 . Sham Treatment placebo device Phase 2 - One Arm : Active Treatment GammaCore Device</detailed_description>
	<mesh_term>Headache</mesh_term>
	<mesh_term>Cluster Headache</mesh_term>
	<criteria>1 . Is ages 18 75 year . 2. diagnosed episodic cluster headache , accordance ICHD2 Classification criterion ( 2ndEd ) : At least 5 attack fulfil follow criterion : Severe severe unilateral orbital , supraorbital and/or temporal pain last 15180 minute untreated Headache accompany least 1 follow : Ipsilateral conjunctival injection and/or lacrimation Ipsilateral nasal congestion and/or rhinorrhea Ipsilateral eyelid edema Ipsilateral forehead facial sweat Ipsilateral miosis and/or ptosis A sense restlessness agitation 3. currently experience cluster headache , clinical history expect continue experience cluster headache period least 4 week . 4. able distinguish CH headache ( i.e . migraine , tensiontype headache ) . 5. capable complete headache pain selfassessments . 6 . [ Intentionally leave blank ] . 7 . Agrees use GammaCore device intend follow requirement study , include followup visit requirement . 8 . Agrees record usage GammaCore device , require study data , report adverse device effect study center within 24 hour adverse device effect . 9. able provide write Informed Consent 1. surgery treat cluster headache . 2. currently take prophylactic medication ( include chronic opioids nonprescribed street drug ) indication CH opinion clinician may interfere study . 3 . [ Intentionally leave blank ] . 4. undergone botulinum toxin injection head and/or neck last 3 month nerve block ( occipital ) head neck last month . 5. history aneurysm , intracranial hemorrhage , brain tumor significant head trauma . 6. lesion ( include lymphadenopathy ) , dysaesthesia , previous surgery abnormal anatomy treatment site . 7. structural intracranial , cervical vascular lesion may potentially cause headache attack . 8. significant pain problem ( include cancer pain , fibromyalgia , trigeminal neuralgia/TACcluster ) might confound study assessment . 9. know suspect severe atherosclerotic cardiovascular disease , severe carotid artery disease ( e.g . bruits history TIA CVA ) , congestive heart failure ( CHF ) , know severe coronary artery disease recent myocardial infarction . 10. history prolong QT interval history clinically significant arrhythmia . 11. abnormal baseline ECG ( e.g . second third degree heart block , atrial fibrillation , atrial flutter , recent history ventricular tachycardia ventricular fibrillation , clinically significant premature ventricular contraction ) . 12. previous bilateral right cervical vagotomy . 13. uncontrolled high blood pressure . 14. currently implant electrical and/or neurostimulator device , include limited cardiac pacemaker defibrillator , vagal neurostimulator , deep brain stimulator , spinal stimulator , bone growth stimulator , cochlear implant . 15. history carotid endarterectomy vascular neck surgery right side . 16. implanted metal cervical spine hardware metallic implant near GammaCore stimulation site . 17. recent repeat history syncope . 18. recent repeat history seizure . 19. known history suspicion substance abuse addiction , overuse acute headache medication headache CH . 20. psychiatric cognitive disorder and/or behavioral problem opinion clinician may interfere study . 21. pregnant , nursing , think become pregnant next 4 month , childbearing year unwilling use accept form birth control . 22. participate therapeutic clinical investigation participate clinical trial precede 30 day . 23 . Belongs vulnerable population condition ability provide inform consent , comply followup requirement , provide selfassessments compromise</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cluster Headache</keyword>
	<keyword>GammaCore</keyword>
	<keyword>vagal nerve stimulation</keyword>
	<keyword>nVNS</keyword>
	<keyword>VNS</keyword>
	<keyword>non invasive</keyword>
	<keyword>vagus nerve stimulation</keyword>
</DOC>